European Crohn´s and Colitis Organisation - ECCO - Home
Call for nominations for participants in the 21st ECCO IBD Intensive Course for Trainees - The British Society of Gastroenterology
Hospira Presents Updates on Biosimilar Inflectra for IBD at 2015 ECCO-IBD Conference
UCLA Center for IBD - Aria Zand presenting his research: DOP026. Work related problems and impaired productivity in patients with inflammatory bowel diseases (IBD) https://www.ecco-ibd.eu/publications/congress-abstract-s/abstracts-2014/item/dop026-work ...
Peter Bossuyt, ECCO-IBD 2022: Risankizumab in Crohn's Disease - Post Hoc Analysis of ADVANCE, MOTIVATE, and FORTIFY - touchIMMUNOLOGY
ECCO 2023 | HealthManagement.org
Journal of Crohn's and Colitis | Oxford Academic
Webcast: New Data at ECCO - Multimedia - ECCO 2022 | CCO
ECCO 2022
PDF) 4th Congress of ECCO Inflammatory Bowel Diseases Impact of antiTNF treatment on Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: real world data in Germany
5 IBD Clinical Development Takeaways from ECCO 2022
Y-ECCO (@Y_ECCO_IBD) / Twitter
ECCO - European Crohn's and Colitis Organisation | eMedEvents
European Crohn´s and Colitis Organisation - ECCO - Home
European Crohn´s and Colitis Organisation - ECCO - Congress Educational Programme
Medflixs - The 17th Congress of European Crohn's and Colitis Organisation, ECCO 2022
A Vall d'Hebron project receives the N-ECCO grant awarded by the European Crohn's and Ulcerative Colitis Organization | Vall d'Hebron Barcelona Hospital Campus
Medflixs - The 15th Congress of European Crohn's and Colitis Organisation, ECCO 2020
ECCO 2022
VEDOKIDS: Vedolizumab seems effective in paediatric IBD - Medical Conferences
Review of the 17th Congress of the European Crohn's and Colitis Organisation (ECCO) - European Medical Journal
A Vall d'Hebron project receives the N-ECCO grant awarded by the European Crohn's and Ulcerative Colitis Organization | Vall d'Hebron Barcelona Hospital Campus